Murine models of susceptibility to tuberculosis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 53, Issue 6, 2005, Pages 469-483

  Beamer, Gillian L ^a   Turner, Joanne ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Lung; Murine; Reactivation; Tuberculosis

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA; TUBERCULIN;

BACTERIAL GENE; BACTERIUM IDENTIFICATION; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; MOUSE STRAIN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REPRODUCIBILITY; REVIEW; SPECIES DIFFERENCE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUBERCULOSIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNE SYSTEM; INTERFERON TYPE II; LUNG; MACROPHAGES; MICE; MICE, INBRED STRAINS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 29844453368     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Actor J. K., Breij E., Wetsel R. A., Hoffmann H., Hunter R. L. Jr. and Jagannath C. (2001): A role for complement C5 in organism containment and granulomatous response during murine tuberculosis. Scand. J. Immunol., 53, 464-474.
2. Actor J. K., Indrigo J., Beachdel C. M., Olsen M., Wells A., Hunter R. L. Jr., Dasgupta A. (2003): Mycobacterial glycolipid cord factor trehalose 6,6′-dimycolate causes a decrease in serum cortisol during the granulomatous response. Neuroimmunomodulation, 10, 270-282.
3. Altare F., Durandy A., Lammas D., Emile J. F., Lamhamedi S., Le Deist F., Drysdale P., Jouanguy E., Doffinger R., Bernaudin F., Jeppsson O., Gollob J. A., Meinl E., Segal A. W., Fischer A., Kumararatne D. and Casanova J. L. (1998): Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science, 280, 1432-1435.
4. Bellamy R., Ruwende C., Corrah T., McAdam K. P., Whittle H. C. and Hill A. V. (1998): Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber. Lung Dis., 79, 83-89.
5. Bellamy R., Ruwende C., Corrah T., McAdam K. P., Whittle H. C. and Hill A. V. (1998): Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med., 338, 640-644.
6. Bellamy R., Beyers N., McAdam K. P., Ruwende C., Gie R., Samaai P., Bester D., Meyer M., Corrah T., Collin M., Camidge D. R., Wilkinson D., Hoal-Van Helden E., Whittle H. C., Amos W., van Helden P. and Hill A. V. (2000): Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc. Natl. Acad. Sci. USA, 97, 8005-8009.
7. Bhatt K., Hickman S. P. and Salgame P. (2004): Cutting edge: A new approach to modeling early lung immunity in murine tuberculosis. J. Immunol., 172, 2748-2751.
8. Bonecini-Almeida M. G., Ho J. L., Boechat N., Huard R. C., Chitale S., Doo H., Geng J., Rego L., Lazzarini L. C., Kritski A. L., Johnson W. D. Jr., McCaffrey T. A. and Silva J. R. (2004): Down-modulation of lung immune responses by interleukin-10 and transforming growth factor β (TGFβ) and analysis of TGFβ receptors I and II in active tuberculosis. Infect. Immun., 72, 2628-2634.
9. Borghi P., Fantuzzi L., Varano B., Gessani S., Puddu P., Conti L., Capobianchi M. R., Ameglio F. and Belardelli F. (1995): Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J. Virol., 69, 1284-1287.
10. Bosio C. M., Gardner D. and Elkins K. L. (2000): Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology. J. Immunol., 164, 6417-6425.
11. Boussiotis V. A., Tsai E. Y., Yunis E. J., Thim S., Delgado J. C., Dascher C. C., Berezovskaya A., Rousset D., Reynes J. M. and Goldfeld A. E. (2000): IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest., 105, 1317-1325.
12. Cardona P.-J., Gordillo S., Diaz J., Tapia G., Amat I., Pallares A., Vilaplana C., Ariza A. and Ausina V. (2003): Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis. Infect. Immun., 71, 5845-5854.
13. + T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect. Immun., 69, 2666-2674.
14. Chackerian A. A., Alt J. M., Perera T. V., Dascher C. C. and Behar S. M. (2002): Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun., 70, 4501-4509.
15. Chan J., Tanaka K., Carroll D., Flynn J. and Bloom B. R. (1995): Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun., 63, 736-740.
16. Chan J., Tian Y., Tanaka K. E., Tsang M. S., Yu K., Salgame P., Carroll D., Kress Y., Teitelbaum R. and Bloom B. R. (1996): Effects of protein calorie malnutrition on tuberculosis in mice. Proc. Natl. Acad. Sci. USA, 93, 14857-14861.
17. Clerici M., Wynn T. A., Berzofsky J. A., Blatt S. P., Hendrix C. W., Sher A., Coffman R. L. and Shearer G. M. (1994): Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest., 93, 768-775.
18. Condos R., Rom W. N. and Schluger N. W. (1997): Treatment of multidrug resistant pulmonary tuberculosis with interferon-γ via aerosol. Lancet, 349, 1513-1515.
19. Condos R., Raju B., Canova A., Zhao B. Y., Weiden M., Rom W. N. and Pine R. (2003): Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients. Infect. Immun., 71, 2058-2064.
20. Cooper A. M., Magram J., Ferrante J. and Orme I. M. (1997): Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med., 186, 39-45.
21. Cooper A. M., Callahan J. E., Griffin J. P., Roberts A. D. and Orme I. M. (1995): Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis. Infect. Immun., 63, 3259-3265.
22. Cooper A. M., Dalton D. K., Stewart T. A., Griffin J. P., Russell D. G. and Orme I. M. (1993): Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med., 178, 2243-2247.
23. Cooper A. M., Roberts A. D., Rhoades E. R., Callahan J. E., Getzy D. M. and Orme I. M. (1995): The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology, 84, 423-432.
24. Corbett E. L., Watt C. J., Walker N., Maher D., Williams B. G., Raviglione M. C. and Dye C. (2003): The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med., 163, 1009-1021.
25. + T cells mediate IFN-γ-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J. Immunol., 171, 4689-4699.
26. Delgado J. C., Tsai E. Y., Thim S., Baena A., Boussiotis V. A., Reynes J. M., Sath S., Grosjean P., Yunis E. J. and Goldfeld A. E. (2002): Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc. Natl. Acad. Sci. USA, 99, 7576-7581.
27. Dorner B. G., Scheffold A., Rolph M. S., Huser M. B., Kaufmann S. H., Radbruch A., Flesch I. E. and Kroczek R. A. (2002): MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc. Natl. Acad. Sci. USA, 99, 6181-6186.
28. Dutt A. K and Stead W. W. (1992): Tuberculosis. Clin. Geriatr. Med., 8, 761-775.
29. Flynn J. L. and Chan J. (2001): Immunology of tuberculosis. Annu. Rev. Immunol., 19, 93-129.
30. Flynn J. L., Goldstein M. M., Chan J., Triebold K. J., Pfeffer K., Lowenstein C. J., Schreiber R., Mak T. W. and Bloom B. R. (1995): Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity, 2, 561-572.
31. Frieden T. R., Sterling T., Pablos-Mendez A., Kilburn J. O., Cauthen G. M., Dooley S. W. (1993): The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med., 328, 521-526.
32. Gerosa F., Nisii C., Righetti S., Micciolo R., Marchesini M., Cazzadori A., Trinchieri G. (1999): CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin. Immunol., 92, 224-234.
33. Globerson A. and Effros R. B. (2000): Ageing of lymphocytes and lymphocytes in the aged. Immunol. Today, 21, 515-521.
34. Goldfeld A. E., Delgado J. C., Thim S., Bozon M. V., Uglialoro A. M., Turbay D., Cohen C. and Yunis E. J. (1998): Association of an HLA-DQ allele with clinical tuberculosis. JAMA, 279, 226-228.
35. Gonzalez-Juarrero M., Turner O. C., Turner J., Marietta P., Brooks J. V. and Orme I. M. (2001): Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect. Immun., 69, 1722-1728.
36. Gruppo V., Turner O. C., Orme I. M. and Turner J. (2002): Reduced up-regulation of memory and adhesion/integrin molecules in susceptible mice and poor expression of immunity to pulmonary tuberculosis. Microbiology, 148, 2959-2966.
37. Haynes L., Linton P. J., Eaton S. M., Tonkonogy S. L. and Swain S. L. (1999): Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J. Exp. Med., 190, 1013-1024.
38. Hernandez-Pando R., De La Luz Streber M., Orozco H., Arriaga K., Pavon L., Al-Nakhli S. A. and Rook G. A. (1998): The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice. Immunology, 95, 234-241.
39. Hirsch C. S., Toossi Z., Othieno C., Johnson J. L., Schwander S. K., Robertson S., Wallis R. S., Edmonds K., Okwera A., Mugerwa R., Peters P. and Ellner J. J. (1999): Depressed T-cell interferon-γ responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis., 180, 2069-2073.
40. Hu C., Mayadas-Norton T., Tanaka K., Chan J. and Salgame P. (2000): Mycobacterium tuberculosis infection in complement receptor 3-deficient mice. J. Immunol., 165, 2596-2602.
41. Huard R. C., Chitale S., Leung M., Lazzarini L. C., Zhu H., Shashkina E., Laal S., Conde M. B., Kritski A. L., Belisle J. T., Kreiswirth B. N., Lapa e Silva J. R. and Ho J. L. (2003): The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10. Infect. Immun., 71, 6871-6883.
42. Jagannath C., Hoffmann H., Sepulveda E., Actor J. K., Wetsel R. A. and Hunter R. (2000): Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scand. J. Immunol., 52, 369-379.
43. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J. F., Newport M., Levin M., Blanche S., Seboun E., Fischer A. and Casanova J. L. (1996): Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med., 335, 1956-1961.
44. Junqueira-Kipnis A.P., Turner J., Gonzalez-Juarrero M., Turner O. C. and Orme I. M. (2004): Stable T-cell population expressing an effector cell surface phenotype in the lungs of mice chronically infected with Mycobacterium tuberculosis. Infect. Immun., 72, 570-575.
45. Keane J., Gershon S., Wise R. P., Mirabile-Levens E., Kasznica J., Schwieterman W. D., Siegel J. N. and Braun M. M. (2001): Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med., 345, 1098-1104.
46. Keller C., Lauber J., Blumenthal A., Buer J. and Ehlers S. (2004): Resistance and susceptibility to tuberculosis analysed at the transcriptome level: lessons from mouse macrophages. Tuberculosis, 84, 144-158.
47. Kinjo Y., Kawakami K., Uezu K., Yara S, Miyagi K., Koguchi Y., Hoshino T., Okamoto M., Kawase Y., Yokota K., Yoshino K., Takeda K., Akira S. and Saito A. (2002): Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. J. Immunol., 169, 323-329.
48. Kochi A. (1991): The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle, 72, 1-6.
49. Kramnik I., Dietrich W.F., Demant P. and Bloom B. R. (2000): Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA, 97, 8560-8565.
50. Lavebratt C., Apt A. S., Nikonenko B. V., Schalling M. and Schurr E. (1999): Severity of tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9. J. Infect. Dis., 180, 150-155.
51. Lehmann J. C., Jablonski-Westrich D., Haubold U., Gutierrez-Ramos J. C., Springer T. and Hamann A. (2003): Overlapping and selective roles of endothelial intercellular adhesion molecule-1 (ICAM-1) and ICAM-2 in lymphocyte trafficking. J. Immunol., 171, 2588-2593.
52. Lenaerts A. J., Chapman P. L. and Orme I. M. (2004): Statistical limitations to the Cornell model of latent tuberculosis infection for the study of relapse rates. Tuberculosis, 84, 361-364.
53. Lyadova I., Yeremeev V., Majorov K., et al. (1998): An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis. Infect Immun 66, 4981-4988.
54. Lyadova I. V., Eruslanov E. B., Khaidukov S. V., Yeremeev V. V., Majorov K. B., Pichugin A. V., Nikonenko B. V., Kondratieva T. K. and Apt A. S. (2000): Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease. J. Immunol., 165,5921-5931.
55. McCune R. M., Feldmann F. M. and McDermott W. (1966): Microbial persistence: characteristics of the sterile state of tubercle bacilli. J. Exp. Med., 123, 469-486.
56. McCune R. M., Feldmann F. M., Lambert H. P. and McDermott W. (1966): Microbial persistence: the capacity of tubercle bacilli to survive sterilization in mouse tissues. J. Exp. Med., 123, 445-468.
57. Medina E. and North R. J. (1996): Evidence inconsistent with a role for the Beg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis. J. Exp. Med., 183, 1045-1051.
58. Medina E. and North R. J. (1998): Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology, 93, 270-274.
59. Medina E. and North R. J. (1999): Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination. Immunology, 96, 16-21.
60. Mitsos L.M., Cardon L.R., Ryan L., LaCourse R., North R. J. and Gros P. (2003): Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs. Proc. Natl. Acad. Sci. USA, 100, 6610-6615.
61. Mohan V. P., Scanga C. A., Yu K., Scott H. M., Tanaka K. E., Tsang E., Tsai M. M., Flynn J. L. and Chan J. (2001): Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect. Immun., 69, 1847-1855.
62. Moore K. W., de Waal Malefyt R., Coffman R. L. and O'Garra A. (2001): Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol., 19, 683-765.
63. Musa S. A., Kim Y., Hashim R., Wang G. Z., Dimmer C. and Smith D. W. (1987): Response of inbred mice to aerosol challenge with Mycobacterium tuberculosis. Infect. Immun., 55, 1862-1866.
64. Newport M. J., Huxley C. M., Huston S., Hawrylowicz C. M., Oostra B. A., Williamson R. and Levin M. (1996): A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med., 335, 1941-1949.
65. North R. J., LaCourse R., Ryan L. and Gros P. (1999): Consequence of Nrampl deletion to Mycobacterium tuberculosis infection in mice. Infect. Immun., 67, 5811-5814.
66. Orme I. M. (1987): Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J. Immunol., 138, 4414-4418.
67. Orme I. M. and Cooper A. M. (1999): Cytokine/chemokine cascades in immunity to tuberculosis. Immunol. Today, 20, 307-312.
68. Pan H., Van B.-S., Rojas M., Shebzukhov Y. V., Zhou H., Kobzik L., Higgins D. E., Daly M. J., Bloom B. R. and Kiamnik I. (2005): lpr1 gene mediates innate immunity to tuberculosis. Nature, 434, 767-772.
69. Pierce C., Dubos R. J. and Middlebrook G. (1947): Infection of mice with mammalian tubercle bacilli grown in tween-albumin liquid medium. J. Exp. Med., 86, 159-174.
70. Radaeva T. V., Nikonenko B. V., Mischenko V. V., Averbakh M. M. and Apt A. S. (2005): Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice. Tuberculosis, 85, 65-72.
71. Rhoades E. R., Frank A. A. and Orme I. M. (1997): Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis., 78, 57-66.
72. Rook G., Baker R., Walker B., Honour J., Jessop D., Hernandez-Pando R., Arriaga K., Shaw R., Zumla A. and Lightman S. (2000): Local regulation of glucocorticoid activity in sites of inflammation. Ann. NY Acad. Sci., 917, 913-922.
73. Rook G. A. and Hernandez-Pando R. (1997): Pathogenetic role, in human and murine tuberculosis, of changes in the peripheral metabolism of glucocorticoids and antiglucocorticoids. Psychoneuroendocrinology, 22 (suppl. 1), S109-113.
74. Sanchez F., Radaeva T. V., Nikonenko B. V., Persson A. S., Sengul S., Schalling M., Schurr E., Apt A. S. and Lavebratt C. (2003): Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice. Infect. Immun., 71, 126-131.
75. Saunders B. M., Frank A. A., Orme I. M. and Cooper A. M. (2002): CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cell. Immunol., 216, 65-72.
76. Scanga C. A., Mohan V. P., Joseph H., Yu K., Chan J. and Flynn J. L. (1999): Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect. Immun., 67, 4531-4538.
77. Stead W. W. and Dutt A. K. (1991): Tuberculosis in elderly persons. Annu. Rev. Med., 42, 267-276.
78. Turner J., Frank A. A. and Orme I. M. (2002): Old mice express a transient early resistance to pulmonary tuberculosis that is mediated by CD8 T cells. Infect. Immun., 70, 4628-4637.
79. Turner J., Corrah T., Sabbally S., Whittle H. and Dockrell H. M. (2000): A longitudinal study of in vitro IFN gamma production and cytotoxic T cell responses of tuberculosis patients in The Gambia. Tuber. Lung Dis., 80, 161-169.
80. Turner J., Frank A. A., Brooks J. V., Gonzalez-Juarrero M. and Orme I. M. (2001): The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4. Exp. Gerontol., 36, 537-545.
81. Turner J., Gonzalez-Juarrero M., Ellis D. L., Basaraba R. J., Kipnis A., Orme I. M. and Cooper A. M. (2002): In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol., 169, 6343-6351.
82. Turner J., Gonzalez-Juarrero M., Saunders B. M., Brooks J. V., Marietta P., Ellis D. L., Frank A. A., Cooper A. M. and Orme I. M. (2001): Immunological basis for reactivation of tuberculosis in mice. Infect Immun 69, 3264-3270.
83. Turner O. C., Keefe R. G., Sugawara I., Yamada H. and Orme I. M. (2003): SWR mice are highly susceptible to pulmonary infection with Mycobacterium tuberculosis. Infect. Immun., 71, 5266-5272.
84. Verbon A., Juffermans N., Van Deventer S. J., Speelman P., Van Deutekom H. and Van Der Poll T. (1999): Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol., 115, 110-113.
85. Vidai S. M., Malo D., Vogan K., Skamene E. and Gros P. (1993): Natural resistance to infection with intracellular parasites: isolation of a candidate for Beg. Cell, 73, 469-485.
86. Wilkinson R. J., Llewelyn M., Toossi Z., Patel P., Pasvol G., Lalvani A., Wright D., Latif M. and Davidson R. N. (2000): Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet, 355, 618-621.